Instructor in Medicine, Dana-Farber Cancer Institute

Hematology

Dr. Matthew S. Davids practices Hematology. He went to medical school at Yale University School of Medicine. Yale University School of Medicine is a one of the best medicals schools. Yale University School of Medicine is ranked 7 in research and 57 in primary care medicine He has 1 awards "Young Scientist Award". Matthew S. Davids, MD has written publications. He has 22 publications published with PubMed. The lastest publication is: 'BCL-2 Antagonism to Target the Intrinsic Mitochondrial Pathway of Apoptosis.' He accepts all Medicare patients.

Publications

---

• BCL-2 Antagonism to Target the Intrinsic Mitochondrial Pathway of Apoptosis.
• The evolving role of hematopoietic cell transplantation in chronic lymphocytic Leukemia.
• The BCL2 antagonist ABT-199 triggers apoptosis, and augments ibrutinib and idelalisib mediated cytotoxicity in CXCR4(Wild-type) and CXCR4(WHIM) mutated Waldenstrom mac...
• Is Bcl-2 a valid target in the treatment of indolent non-Hodgkin Lymphoma?
• Ibrutinib: a first in class covalent inhibitor of Bruton's tyrosine kinase.
• Selective bcl-2 inhibition to treat chronic lymphocytic Leukemia and non-hodgkin lymphoma.
• Fatty intra-abdominal lymph nodes in chronic lymphocytic Leukemia.
• Association of Advanced Leukemic Stage and Skin Cancer Tumor Stage With Poor Skin Cancer Outcomes in Patients With Chronic Lymphocytic Leukemia.
• Detection of circulating tumour DNA in patients with aggressive B-cell non-Hodgkin Lymphoma.
• A phase I study of escalated dose subcutaneous alemtuzumab given weekly with rituximab in relapsed chronic lymphocytic Leukemia/small lymphocytic lymphoma.
• Overcoming stroma-mediated treatment resistance in chronic lymphocytic Leukemia through BCL-2 inhibition.
• Phosphoinositide 3'-kinase inhibition in chronic lymphocytic Leukemia.
• Prognostic factors for patients with diffuse large B cell Lymphoma and transformed indolent Lymphoma undergoing autologous stem cell transplantation in the positron em...
• ABT-199: Taking Dead Aim at BCL-2.
• Targeting the B cell receptor pathway in chronic lymphocytic Leukemia.
• BCL2 Suppresses PARP1 Function and Nonapoptotic Cell Death.
• Assessing surge capacity for radiation victims with marrow toxicity.
• Serum free light chain analysis.
• The molecular pathogenesis of Myelodysplastic syndromes.
• Medical management of radiation victims in the United States.
• Response to a novel multitargeted tyrosine kinase inhibitor pazopanib in metastatic Merkel Cell carcinoma.

Schools

---

• Yale Univ Sch Of Med

• New York Presbyterian Hospital

Procedures Preformed

---

• Bone Marrow Transplant
• Plasmapheresis
• Thoracentesis

Conditions Treated

---

• Acute Leukemia
• Anemia
• Breast Cancer
• Burkitt's Lymphoma
• View All

Doctors Specialties

---

• Hematology
• Medical Oncology
• Oncology

Accepted Insurances

---

• Aetna HMO
• Choice Plus POS II
• Blue Card PPO
• BlueConnect HMO
• Blue with Managed Care Behavioral Health HMO
• Preferred Blue PPO
• Cigna HMO
• Cigna PPO
• Great West Healthcare-Cigna PPO
• Open Access Plus
• Commercial Insurance Company
• Fallon Community Health Plan
• First Health (Coventry Health Care) PPO
• Medicare Advantage PFFS
• Choice Care PPO
• Medicare MCR
• MultiPlan PPO
• PHCS Network PPO
• Network Health
• Tufts PPO
• Choice Plus POS
• Navigate HMO
• Navigate POS
• Options PPO
• United Healthcare

Awards

---

• Young Scientist Award

Education

---

• New York Presbyterian Hospital - Cornell Campus
• Yale University School of Medicine

Hospital

---

• Brigham and Women's Hospital
• Dana-Farber Cancer Institute

Drug Facts

---

NPI NUMBER		1659541522
NPPES Provider LastName		DAVIDS
NPPES Provider FirstName		MATTHEW
NPPES Provider ZIPCode		022155418
NPPES Provider State		MA
Specialty Description		Medical Oncology
Total Claim Count		118.0
Distinct Opioid Count		0.0
Opioid Claim Count		0.0
Percent Opioid Claims		0.0

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1659541522
Last Name Of The Provider	DAVIDS
First Name Of The Provider	MATTHEW
View All

Similar Doctors

---

	Dr. Francois Mercier, MD This Doctor is OpenDoctor Recommended.
	Dr. Hsiu-Hung Wang, MD
	Dr. Craig C. Earle, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Xiuning Le, MD
	Dr. Mark M. Pomerantz, MD This Doctor is OpenDoctor Recommended.
	Dr. Shuchi S. Pandya, MD This Doctor is OpenDoctor Recommended.
	Dr. Parul Bhargava, MD This Doctor is OpenDoctor Recommended.
	Dr. Nancy U. Lin, MD
	Dr. Dejan Juric, MD This Doctor is OpenDoctor Recommended.
	Dr. Jamie E. Potosek, MD This Doctor is OpenDoctor Recommended.
	Dr. Brett Glotzbecker, MD This Doctor is OpenDoctor Recommended.
	Dr. Khanh T. Do, MD
	Dr. Toni K. Choueiri, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Murray M. Bern, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. John P. Doweiko, MD
	Dr. Robert W. Bunting, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog